- Home
- PRSO vs KLTO Comparison
PRSO vs KLTO Comparison
Compare PRSO & KLTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRSO
- KLTO
- Stock Information
- Founded
- PRSO 2008
- KLTO 2019
- Country
- PRSO United States
- KLTO United States
- Employees
- PRSO N/A
- KLTO N/A
- Industry
- PRSO Semiconductors
- KLTO
- Sector
- PRSO Technology
- KLTO
- Exchange
- PRSO Nasdaq
- KLTO NYSE
- Market Cap
- PRSO 4.3M
- KLTO 4.8M
- IPO Year
- PRSO 2001
- KLTO N/A
- Fundamental
- Price
- PRSO $1.04
- KLTO $0.17
- Analyst Decision
- PRSO Strong Buy
- KLTO
- Analyst Count
- PRSO 2
- KLTO 0
- Target Price
- PRSO $3.38
- KLTO N/A
- AVG Volume (30 Days)
- PRSO 221.7K
- KLTO 153.9K
- Earning Date
- PRSO 05-12-2025
- KLTO 05-19-2025
- Dividend Yield
- PRSO N/A
- KLTO N/A
- EPS Growth
- PRSO N/A
- KLTO N/A
- EPS
- PRSO N/A
- KLTO N/A
- Revenue
- PRSO $14,573,000.00
- KLTO N/A
- Revenue This Year
- PRSO $3.74
- KLTO N/A
- Revenue Next Year
- PRSO $37.09
- KLTO N/A
- P/E Ratio
- PRSO N/A
- KLTO N/A
- Revenue Growth
- PRSO 5.99
- KLTO N/A
- 52 Week Low
- PRSO $0.52
- KLTO $0.11
- 52 Week High
- PRSO $2.34
- KLTO $13.10
- Technical
- Relative Strength Index (RSI)
- PRSO 67.00
- KLTO N/A
- Support Level
- PRSO $0.77
- KLTO N/A
- Resistance Level
- PRSO $1.20
- KLTO N/A
- Average True Range (ATR)
- PRSO 0.12
- KLTO 0.00
- MACD
- PRSO 0.02
- KLTO 0.00
- Stochastic Oscillator
- PRSO 69.81
- KLTO 0.00
About PRSO Peraso Inc.
Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.
About KLTO KLOTHO NEUROSCIENCES INC
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.